[Chronic active Epstein-Barr virus infection with multiple vascular lesions successfully treated by cord blood transplantation]

Rinsho Ketsueki. 2020;61(10):1502-1507. doi: 10.11406/rinketsu.61.1502.
[Article in Japanese]

Abstract

An 18-year-old woman presented with fever and liver dysfunction. Computed tomography showed lymphadenopathy, hepatosplenomegaly, and vascular lesions such as aneurysms and irregularities at multiple arteries, including coronary arteries. Based on the high copy number of Epstein-Barr virus (EBV)-DNA in the peripheral blood, EBV-infected CD4+T cells, and the proliferation of EBER-positive cells in the bone marrow, chronic active EBV infection (CAEBV) was diagnosed. Although the fever and liver dysfunction improved as a result of the initial immunosuppressive therapy and multiagent chemotherapy, EBV-DNA remained high. Moreover, she experienced repeated episodes of angina pectoris due to coronary arterial lesions. Therefore, cord blood transplantation was performed after reduced-intensity conditioning. EBV-DNA decreased quickly after initiating the conditioning and became undetectable at day 7 after the transplant. Vascular lesions did not progress after the transplant, and the patient's angina pectoris resolved. At 2.5 years after the transplant, she is alive without disease recurrence. The prognosis of CAEBV with vascular lesions is especially poor. Although the indication for allogeneic hematopoietic stem cell transplantation (HSCT) is difficult to determine in such cases, the clinical course of our case suggests that allogenic HSCT could be safely performed under appropriate management and could successfully control not only CAEBV but also vascular lesions.

Keywords: Chronic active Epstein-Barr virus infection; Cord blood transplantation; Coronary artery lesions; Vascular lesions.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Chronic Disease
  • Cord Blood Stem Cell Transplantation*
  • Epstein-Barr Virus Infections* / complications
  • Female
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Transplantation Conditioning